Table 1.
Correlation between PoV CTC phenotype count and baseline characteristics.
| Variables | n | T-CTC | P | E-CTC | P | H-CTC | P | M-CTC | P |
|---|---|---|---|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | ||||||
| Gender | 0.487 | 0.142 | 0.742 | 0.061 | |||||
| Male | 34 | 7.5 (4.75-13.25) | 2 (1-4.25) | 4 (1.75-8) | 0 (0-1.25) | ||||
| Female | 26 | 7 (3-13.25) | 2 (0.75-3) | 4.5 (2-9.5) | 0 (0-0) | ||||
| Age (years) | 0.470 | 0.234 | 0.829 | 0.452 | |||||
| ≤65 | 38 | 7 (4-14) | 2 (1-3.25) | 4 (2-8.5) | 0 (0-1) | ||||
| >65 | 22 | 7.5 (2-13) | 1.5 (0-4.25) | 5 (1.75-8.25) | 0 (0-1) | ||||
| Diabetes | 0.336 | 0.343 | 0.099 | 0.942 | |||||
| No | 46 | 7 (3.75-13) | 2 (1-5) | 4 (1-7.5) | 0 (0-1) | ||||
| Yes | 14 | 9.5 (4.75-15) | 2 (1-3) | 7 (3-13) | 0 (0-1.25) | ||||
| Hepatitis | 0.959 | 0.925 | 0.795 | 0.902 | |||||
| No | 51 | 7 (4-13) | 2 (1-4) | 5 (2-8) | 0 (0-1) | ||||
| Yes | 9 | 7 (3.5-13.5) | 2 (1-3.5) | 3 (2.5-9) | 0 (0-2) | ||||
| Pre-op CA19-9 (u/ml) | 0.087 | 0.853 | 0.038 | 0.335 | |||||
| ≤37 | 23 | 6 (3-10) | 2 (1-4) | 3 (1-6) | 0 (0-1) | ||||
| >37 | 37 | 8 (5-14) | 2 (1-3.5) | 6 (3-9.5) | 0 (0-1.5) | ||||
| Post-op CA19-9 (u/ml) | 0.013* | 0.030* | 0.012* | 0.339 | |||||
| ≤37 | 40 | 6.5 (3-11) | 2 (0.25-3) | 3 (1-7) | 0 (0-1) | ||||
| >37 | 20 | 11.5 (6.25-18.75) | 3 (1.25-5.75) | 7 (3.25-15.25) | 0 (0-0.75) | ||||
| T stage | 0.061 | 0.006* | 0.514 | 0.367 | |||||
| T1-T2 | 30 | 6.5 (3-10.5) | 2 (0-2) | 4 (2-7) | 0 (0-1) | ||||
| T3 | 30 | 10 (4.75-17.25) | 3 (1-5) | 5.5 (1-11.5) | 0 (0-2) | ||||
| Tumor location | 0.242 | 0.099 | 0.859 | 0.349 | |||||
| Head、neck | 29 | 9 (4-16) | 3 (1-4.5) | 5 (1-10.5) | 0 (0-1.5) | ||||
| Body、tail | 31 | 7 (3-13) | 2 (1-3) | 4 (2-8) | 0 (0-0) | ||||
| Lymph node invasion | 0.141 | 0.810 | 0.207 | 0.014* | |||||
| N0 | 30 | 6.5 (3-11.5) | 2 (0.75-3.25) | 3.5 (1.75-7.25) | 0 (0-0) | ||||
| N1-N2 | 30 | 8.5 (4-14.75) | 2 (1-4) | 5.5 (2.75-10) | 0 (0-2.25) | ||||
| TNM stage 8th AJCC | 0.852 | 0.858 | 0.795 | 0.710 | |||||
| IA-IIB | 51 | 7 (4-13) | 2 (1-3) | 4 (2-8) | 0 (0-1) | ||||
| III | 9 | 8 (3-21) | 2 (0.5-4.5) | 3 (1-15) | 0 (0-1.5) | ||||
| Nerve invasion | 0.064 | 0.128 | 0.240 | 0.225 | |||||
| No | 34 | 7 (3-10) | 2 (0-3) | 4 (2-7) | 0 (0-1) | ||||
| Yes | 26 | 11 (4.75-17.25) | 2.5 (1-4.25) | 6.5 (1.75-13) | 0 (0-2) | ||||
| Differentiation | 0.125 | 0.201 | 0.375 | 0.028* | |||||
| High | 36 | 7 (3-11.5) | 2 (1-3) | 3.5 (2-7) | 0 (0-0) | ||||
| Middle and low | 24 | 10.5 (4.5-14) | 2.5 (1-5) | 5 (2.25-10.75) | 0.5 (0-2) | ||||
| Recurrence | 0.025* | 0.021* | 0.067 | 0.309 | |||||
| No | 49 | 7 (4-11.5) | 2 (1-3) | 4 (2-7) | 0 (0-1) | ||||
| Yes | 11 | 17 (6-23) | 5 (1-7) | 11 (3-18) | 0 (0-0) | ||||
| Metastasis | 0.068 | 0.075 | 0.616 | <0.001* | |||||
| No | 42 | 7 (3-11) | 2 (1-3) | 4 (2-8) | 0 (0-0) | ||||
| Yes | 18 | 12 (5.5-15) | 3 (2-4.25) | 5 (1.5-10) | 2 (0.75-3) | ||||
| Death | 0.278 | 0.070 | 0.439 | <0.001* | |||||
| No | 43 | 7 (3-13) | 2 (1-3) | 4 (2-9) | 0 (0-0) | ||||
| Yes | 17 | 12 (5-13.5) | 3 (1.5-5) | 4 (0.5-7.5) | 1 (0-3) |
Pre-op, preoperative; post-op, postoperative.
Bold values indicate that the results were statistically significant.